Different Glycemic Index (GI) Values in 7 Food Products

April 9, 2015 updated by: Danone Asia Pacific Holdings Pte, Ltd.

In-Vivo Glycemic Index (GI) and Insulinemic Index (II) Testing of 7 Test Foods in Total (5 Milk-based Beverage and 2 Standard Breakfast Items)

This study is initiated to investigate the glycemic index value of seven food products.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Singapore
      • Singapore, Singapore
        • Temasek Polytechnic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy males or non-pregnant females at least 6 weeks postpartum, non-lactating and aged 21-60yrs old in both groups.
  • They should not suffer from any chronic diseases.
  • no known food allergy or intolerance.
  • no medications known to affect glucose tolerance(excluding oral contraceptives). Note: stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable.

Exclusion Criteria:

  • Age less than 21 years old and greater than 60 years old.
  • known history of diabetes mellitus or the use of antihyperglycemic drugs or insulin to treat diabetes and related conditions.
  • known history of AIDS, hepatitis, renal or heart disease or any other serious complications that may interfere with glucose metabolism.
  • subjects using any medication (eg steroids, protease inhibitors or antipsychotics, etc.) that would interfere with the digestion and nutrient absorption.,
  • subjects having gastrointestinal diseases that may interfere with nutrient absorption, distribution, metabolism, excretion and have no known food allergies.
  • a major medical or surgical event requiring hospitalisation within the preceding 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Arm 1

To compare the Glycemic Index value of seven test foods:

Low GI standard Breakfast Medium GI standard Breakfast Nutritional pregnant milk supplement Nutritional product for diabetics Pregnant and lactation women milk powder Nutritional drinks for diabetics Test product
Other: Low GI Standard Breakfast
Low GI Standard Breakfast
Other: Medium GI Standard Breakfast
Medium GI Standard Breakfast
Other: Enfamama A+
Nutritional pregnant milk supplement
Other: Glucerna Triple Care
Nutritional product for diabetics
Other: Dumex Precima
Pregnant and lactation women milk powder
Other: Diasip
Nutritional drinks for diabetics
Other: Test product
Test product not patented yet
Other Names:
  • Not patented yet, cannot disclose name.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycemic index values of all seven products
Time Frame: 120 minutes post administration
Glycemic index values at 120 minutes post adminstration.
120 minutes post administration

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Danone Asia Pacific Holdings Pte, Ltd.

Investigators

  • Principal Investigator: Kalpana Bhaskaran, Dr, Temasek Polytechnic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Actual)

January 1, 2015

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

September 12, 2014

First Submitted That Met QC Criteria

October 27, 2014

First Posted (Estimate)

October 30, 2014

Study Record Updates

Last Update Posted (Estimate)

April 13, 2015

Last Update Submitted That Met QC Criteria

April 9, 2015

Last Verified

April 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • GDM.1.C/D

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe